Xiaomin Su, Ph.D.
Affiliations: | 2008 | University of Rochester, Rochester, NY |
Area:
Neuroscience BiologyGoogle:
"Xiaomin Su"Mean distance: 17.71 (cluster 11)
Parents
Sign in to add mentorHoward J. Federoff | grad student | 2008 | Rochester | |
(alpha-synuclein and microglial activation in Parkinson's disease.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Su X, Fischer DL, Li X, et al. (2017) Alpha-Synuclein mRNA Is Not Increased. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Su X, Chu Y, Kordower JH, et al. (2015) PGC-1α Promoter Methylation in Parkinson's Disease. Plos One. 10: e0134087 |
Su X, Federoff HJ. (2014) Immune responses in Parkinson's disease: interplay between central and peripheral immune systems. Biomed Research International. 2014: 275178 |
Huang L, Su X, Federoff HJ. (2013) Single-chain fragment variable passive immunotherapies for neurodegenerative diseases. International Journal of Molecular Sciences. 14: 19109-27 |
Huang L, Shimoji M, Wang J, et al. (2013) Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 840-51 |
Valles F, Fiandaca MS, Eberling JL, et al. (2010) Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery. 67: 1377-85 |
Kells AP, Eberling J, Su X, et al. (2010) Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 9567-77 |
Su X, Kells AP, Huang EJ, et al. (2009) Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys. Human Gene Therapy. 20: 1627-40 |
Su X, Federoff HJ, Maguire-Zeiss KA. (2009) Mutant alpha-synuclein overexpression mediates early proinflammatory activity. Neurotoxicity Research. 16: 238-54 |
Johnston LC, Su X, Maguire-Zeiss K, et al. (2008) Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1392-9 |